Natalie J. Shiff

1.7k total citations
57 papers, 579 citations indexed

About

Natalie J. Shiff is a scholar working on Hematology, Rheumatology and Speech and Hearing. According to data from OpenAlex, Natalie J. Shiff has authored 57 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 31 papers in Rheumatology and 21 papers in Speech and Hearing. Recurrent topics in Natalie J. Shiff's work include Autoimmune and Inflammatory Disorders Research (42 papers), Adolescent and Pediatric Healthcare (21 papers) and Spondyloarthritis Studies and Treatments (18 papers). Natalie J. Shiff is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (42 papers), Adolescent and Pediatric Healthcare (21 papers) and Spondyloarthritis Studies and Treatments (18 papers). Natalie J. Shiff collaborates with scholars based in Canada, United States and United Kingdom. Natalie J. Shiff's co-authors include Lori B. Tucker, Jaime Guzmán, Kiem Oen, Lisa M. Lix, Roberta Berard, Susanne M. Benseler, Roman Juřenčák, Ciarán M. Duffy, Alan Rosenberg and Dorcas Beaton and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Medical Internet Research and Lara D. Veeken.

In The Last Decade

Natalie J. Shiff

56 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natalie J. Shiff Canada	16	338	219	179	90	69	57	579
Esi M. Morgan United States	15	336 1.0×	193 0.9×	175 1.0×	165 1.8×	75 1.1×	35	695
Debajit Sen United Kingdom	12	213 0.6×	110 0.5×	244 1.4×	79 0.9×	47 0.7×	47	535
A. Myers United Kingdom	13	474 1.4×	253 1.2×	174 1.0×	105 1.2×	128 1.9×	16	810
Elizabeth A. Kessler United States	9	187 0.6×	100 0.5×	78 0.4×	33 0.4×	73 1.1×	17	458
L. Nandini Moorthy United States	14	272 0.8×	147 0.7×	306 1.7×	67 0.7×	14 0.2×	33	550
T Southwood United Kingdom	11	195 0.6×	174 0.8×	83 0.5×	113 1.3×	38 0.6×	23	479
Nadia Luca Canada	13	193 0.6×	204 0.9×	44 0.2×	144 1.6×	35 0.5×	38	499
Erica Lawson United States	14	98 0.3×	194 0.9×	187 1.0×	130 1.4×	48 0.7×	32	504
Michelle Batthish Canada	13	160 0.5×	105 0.5×	94 0.5×	36 0.4×	47 0.7×	44	436
Janet Ellsworth Canada	11	171 0.5×	75 0.3×	141 0.8×	45 0.5×	45 0.7×	23	422

Countries citing papers authored by Natalie J. Shiff

Since Specialization

Citations

This map shows the geographic impact of Natalie J. Shiff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie J. Shiff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie J. Shiff more than expected).

Fields of papers citing papers by Natalie J. Shiff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie J. Shiff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie J. Shiff. The network helps show where Natalie J. Shiff may publish in the future.

Co-authorship network of co-authors of Natalie J. Shiff

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie J. Shiff. A scholar is included among the top collaborators of Natalie J. Shiff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie J. Shiff. Natalie J. Shiff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mease, Philip J., Shannon Ferrante, Natalie J. Shiff, et al.. (2024). Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors. Advances in Therapy. 42(2). 734–751. 1 indexed citations

Walsh, Jessica A., Ruizhi Zhao, Natalie J. Shiff, et al.. (2024). Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors. Drugs - Real World Outcomes. 11(3). 487–499. 3 indexed citations

Mease, Philip J., Alexis Ogdie, John Tesser, et al.. (2024). Improvements in Patient‐Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real‐World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. ACR Open Rheumatology. 6(5). 304–311. 1 indexed citations

Coates, Laura C., Laure Gossec, M. Shawi, et al.. (2024). Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study. RMD Open. 10(1). e003977–e003977. 5 indexed citations

Curtis, Jeffrey R., Atul Deodhar, Enrique R. Soriano, et al.. (2024). Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials. Rheumatology and Therapy. 11(6). 1501–1517. 2 indexed citations

Mease, Philip J., Xenofon Baraliakos, Vinod Chandran, et al.. (2024). Persistent Patient‐Level Effect of Guselkumab at Consecutive 8‐Week Dosing Visits and Over Time in Patients With Active Psoriatic Arthritis: Post Hoc Analysis of a 2‐Year, Phase 3, Randomized, Controlled Study. ACR Open Rheumatology. 6(12). 880–890. 2 indexed citations

Soriano, Enrique R., et al.. (2023). AB1088 EARLY CLINICAL IMPROVEMENT AS PREDICTOR OF LONG-TERM HEALTH-RELATED QUALITY OF LIFE IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB: POST-HOC ANALYSIS THROUGH 2 YEARS OF A PHASE-3 STUDY. Annals of the Rheumatic Diseases. 82. 1765–1766. 1 indexed citations

Mease, Philip J., Alexis Ogdie, John Tesser, et al.. (2023). Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. Rheumatology and Therapy. 10(6). 1479–1501. 9 indexed citations

Schechtman, Joy, Alan Kivitz, Natalie J. Shiff, et al.. (2023). Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study. BMC Rheumatology. 7(1). 5–5. 1 indexed citations

10.

Deodhar, Atul, Soumya D. Chakravarty, Natalie J. Shiff, et al.. (2022). Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis. JCR Journal of Clinical Rheumatology. 28(8). 420–423. 1 indexed citations

11.

Tesser, John, Natalie J. Shiff, Soumya D. Chakravarty, et al.. (2022). Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry. Clinical Rheumatology. 41(8). 2319–2327. 2 indexed citations

12.

Barber, Claire, Cheryl Barnabé, Susanne M. Benseler, et al.. (2020). Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis. Pediatric Rheumatology. 18(1). 22–22. 11 indexed citations

13.

Barber, Claire, Diane Lacaille, Peter Faris, et al.. (2020). Evaluating Quality of Care for Rheumatoid Arthritis for the Population of Alberta Using System-level Performance Measures. The Journal of Rheumatology. 48(4). 482–485. 9 indexed citations

14.

Stinson, Jennifer, Chitra Lalloo, Amos Hundert, et al.. (2020). Teens Taking Charge: A Randomized Controlled Trial of a Web-Based Self-Management Program With Telephone Support for Adolescents With Juvenile Idiopathic Arthritis. Journal of Medical Internet Research. 22(7). e16234–e16234. 19 indexed citations

15.

Barber, Claire, Deborah A. Marshall, Cheryl Barnabé, et al.. (2020). A Population‐Based Approach to Reporting System–Level Performance Measures for Rheumatoid Arthritis Care. Arthritis Care & Research. 73(5). 640–648. 15 indexed citations

16.

Barber, Claire, Carter Thorne, Vandana Ahluwalia, et al.. (2018). Feasibility of Measurement and Adherence to System Performance Measures for Rheumatoid Arthritis in 5 Models of Care. The Journal of Rheumatology. 45(11). 1501–1508. 13 indexed citations

17.

Cellucci, Tania, Jaime Guzmán, Ross E. Petty, et al.. (2016). Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association. The Journal of Rheumatology. 43(10). 1773–1776. 20 indexed citations

18.

Graham, Brett, et al.. (2016). Hashimoto Encephalopathy Presenting With Stroke-Like Episodes in an Adolescent Female: A Case Report and Literature Review. Pediatric Neurology. 59. 62–70. 15 indexed citations

19.

Shiff, Natalie J., Lisa M. Lix, Kiem Oen, et al.. (2014). Chronic inflammatory arthritis prevalence estimates for children and adolescents in three Canadian provinces. Rheumatology International. 35(2). 345–350. 10 indexed citations

20.

Hamzavi, Iltefat, Natalie J. Shiff, Zhiwei Huang, et al.. (2006). Spectroscopic assessment of dermal melanin using blue vitiligo as an in vivo model. Photodermatology Photoimmunology & Photomedicine. 22(1). 46–51. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact